venBio Global Strategic — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
BiotechCambridge, US
Praveen Tipirneni(Executive Officer, Director)
BoardMichelle Doig(Director)inMichael Gladstone(Director)inXiaodi Su(Director)
Board seatAaron Royston· per SEC Form D · $37.5M raise · filed Jan 2026
Co-investorsAtlas VentureOmega Funds
Entact is a drug discovery company developing treatments for patients.
BiotechDeep TechWatertown, US
Victoria Richon(Executive Officer, Director, Promoter)Ruben Tommasi(Chief Scientific Officer)Michael Gutch(Chief Operating Officer)Alon Lazarus(Director)
BoardAndrew Sinclair(Director)Anna French(Director)
Board seatRichard Gaster· per SEC Form D · $10M raise · filed Jun 2026
Co-investorsvenBio Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.